期刊文献+

革兰阳性球菌血流感染预后危险因素分析 被引量:8

Prognotic Risk Factors of Gram Positive Coccus Bloodstream Infection
原文传递
导出
摘要 目的探讨影响革兰阳性球菌血流感染患者预后的危险因素。方法采用回顾性研究方法,选择我院2013年1月至2015年4月收治的革兰阳性球菌血流感染患者93例。根据28 d生存情况将患者分为存活组和死亡组,收集患者一般临床资料、基础疾病、有创操作等,通过多因素Logistic回归分析确定独立危险因素。结果死亡组患者的白蛋白水平低于存活组(P<0.05),D-二聚体、APACHEⅡ评分、合并机械通气、深静脉置管的比例明显高于存活组(P<0.05)。肠球菌血流感染患者合并糖尿病、外科术后、肿瘤、肾功能衰竭比例均高于其他球菌组(P<0.05),但与金黄色葡萄球菌组比较上述合并症比例无明显差异(P>0.05)。ROC曲线分析提示APACHEⅡ评分和白蛋白预测28 d病死率的ROC曲线下面积(AUC)最大值分别0.768和0.775,以APACHEⅡ评分>22.5分作为预测28 d死亡的临界点,敏感性为70.0%,特异性为81.2%;以白蛋白<32.5 g/L作为预测28 d死亡的临界点,敏感性为55.3%,特异性为86.7%。28 d病死率Logistic多因素分析显示仅低白蛋白水平是预测革兰阳性球菌血流感染28 d病死率的独立预后指标(P<0.05)。结论合并糖尿病、外科术后、肿瘤、肾功能衰竭的患者需警惕肠球菌感染,低白蛋白血症提示革兰阳性球菌血流感染预后不良。 Objective To explore the prognostic risk factors for patients with gram positive coccus bloodstream infections. Methods By retrospective analysis, 93 patients with gram positive coccus bloodstream infections were recruited fromthe China-Japan Friendship Hospital during January 2013 to April 2015. According to the 28-day survival situation, the patients were divided into a survival group and a death group. The clinical data including basic diseases and invasive operation were collected. Logistic regression analysis was used to evaluate the risk factors for predicting prognosis. Results The albumin concentration in the death group was lower than that in the survival group ( P 〈 0. 05 ) . The D-Dimer concentration, APACHEⅡ scores, the percentage of patients with mechanical ventilation, and the percentage of patients with deep venous cannels in the death group were all higher than those in the survival group ( P 〈 0. 05) . The percentages with diabetes mellitus, surgery, tumor, renal failure in the patients with enterococcus bloodstream infections were much higher than those patients with other grampositive coccus bloodstream infections ( P 〈 0. 05) , but were not different with those patients with Staphylococcus aureus bloodstream infection ( P 〉 0. 05) . The APACHEⅡ score and albumin concentration had statistical significance for predicting the 28-day and 90-day mortality. The area under the receiver operating characteristic ( ROC) curve was 0. 768 and 0. 775. If using APACHEⅡ score 〉22. 5 as cut off value for predicting death in 28 days, the sensitivity was 70. 0%, and the specificity was 81. 2% . If Using albumin concentration 〈 32. 5 g/L as a cutoff value for predicting death in 28 days, the sensitivity was 55. 3% , and the specificity was 86. 7% . The logistic multifactor analysis revealed only the lower albumin concentration was an independent prognostic factor for 28-day mortality of the patients with gram positive coccus bloodstream infections ( P 〈 0. 05) . Conclusions The patients with diabetes mellitus, surgery, tumor, and renal failure need to be cautious of enterococcus bloodstream infection. The lowalbumin concentration suggests a poor prognosis in patients with gram positive coccus bloodstream infections.
出处 《中国呼吸与危重监护杂志》 CAS 北大核心 2016年第1期7-11,共5页 Chinese Journal of Respiratory and Critical Care Medicine
基金 首都临床特色应用研究(编号:Z131107002213038)
关键词 革兰阳性球菌 血流感染 预后 危险因素 Gram positive coccus Bloodstream infections Prognosis Risk factors
  • 相关文献

参考文献12

  • 1康焰.脓毒症的现代诊断与治疗[J].中国呼吸与危重监护杂志,2009,8(2):104-105. 被引量:16
  • 2Marra AR, Camargo LF, Pignatari AC, et al. Nosocomial bloodstream infections in Brazilian hospitals:analysis of 2563 cases from a prospective nationwide surveillance study. J Clin Microbiol, 2011,49 : 1866-1871.
  • 3vail der Kooi TI, Manniim J, Wille JC, et al. Prevalence of nosocomial infections in The Netherlands. 2007-2008 : results of the first four national studies. J Hosp Infect ,2010,75 : 168-172.
  • 4张黎,刘正印,徐英春,李太生,杨启文,王爱霞.成人原发血流感染494例临床分析[J].中华医学杂志,2012,92(13):894-898. 被引量:20
  • 5何超,陈知行,郭培玲,谢轶,康梅.重症患者血培养病原菌的分布及耐药性分析[J].中国呼吸与危重监护杂志,2012,11(2):153-156. 被引量:12
  • 6汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 7魏泽庆,沈萍,陈云波,肖永红,李兰娟.Mohnarin 2011年度报告:血流感染细菌构成及耐药性[J].中华医院感染学杂志,2012,22(24):5497-5502. 被引量:110
  • 8Libert M, Elkholti M, Massaut J, et al. Risk factors for meticilin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. J Hosp Infect, 2008,68 : 17-24.
  • 9Vincent JL, Dubois M J, Navickis ILl, et al. Hypoalbuminemia in acute illness:is there a rationale for intervention.'? A meta analysis of cohort studies and controlled trials. Ann Surg,2003 ,237 :319-334.
  • 10Zimmerman JE, Kramer AA, McNair DS, et al. Acute Physiology and Chronic Health Evaluation (APACHE) IV:hospital mortality assessment for today' s critically ill patients. Crit Care Med, 2006, 34 : 1297-1310.

二级参考文献87

  • 1骆俊,吴菊芳,朱德妹,李光辉,张婴元,汪复.上海市华山医院血流感染患者的病原学和临床研究[J].中华传染病杂志,2006,24(1):29-34. 被引量:40
  • 2Angus DC, Linde-Zwirble WT, Clermont G, et al. Epidemiology of severe sepsis in the United States : analysis of incidence, outcome, and associated costs of care. Crit Care Med ,2001,29 :1303-1310.
  • 3Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest, 1992,101:1644-1655.
  • 4Levy MM,Fink MP, Marshall JC, et al. SCCM/ESICM/ACCP/ATS/ SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med,2003,31 : 1250-1256.
  • 5Balci C, Sungurtekin H, Gurses E, et al. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care,2003,7: 85 -90.
  • 6Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med ,2001, 345 : 1368-1377.
  • 7van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med ,2006,354:449-461.
  • 8Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med,2004,30:536-555.
  • 9Clinical Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing [S]. M100-S19,2009.
  • 10Clinical Laboratory crobial Dilution and Standard Institute Disk Susceptibility Methods for Antimi Testing of Infrequent ly Isolated or Fastidious Bacteria [S]. Approved Guideline M45-A, 2006, 26(19).

共引文献560

同被引文献80

引证文献8

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部